Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 837.85
+5.55 (0.67%)
Aug 28, 2026, 3:29 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 207.39 billion as of August 28, 2026. Its market cap has increased by 82.03% in one year.
Market Cap
207.39B
Enterprise Value
213.17B
Revenue
56.32B
Ranking
n/a
PE Ratio
31.31
Stock Price
837.85
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 207.39B, an increase of 126,591.22%. That is a compound annual growth rate of 35.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 207.39B | 42.78% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 444.40B |
| Emcure Pharmaceuticals | 354.59B |
| Wockhardt | 321.26B |
| Piramal Pharma | 290.22B |
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |
| Alembic Pharmaceuticals | 159.89B |